Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia announces expansion in preclinical R&D to drive faster drug safety decisions

By Author Proscia | March 20, 2023

Proscia is extending the scalable, intuitive Concentriq for Research to increasingly drive preclinical R&D with new features and services including robust capabilities for GLP compliance, a new Studies module that streamlines toxicopathology workflows, and expanded Automated Quality Control.

Our website uses cookies. By using this site, you agree to its use of cookies.